KaJ Labs Commits $23 Million to Build Multichain AI NFT Platform Colle AI (COLLE) 
CO2 Lock Corp. Announces the Appointment of Mr. Scott Larson as Chief Executive Officer 
SATO Technologies Corp. Announces April 2024 Bitcoin Computing Operational Update 
Thermal Energy Announces $1.9 million Turn-key Heat Recovery Project for a Global Materials Company 
LinkDaddy Announces Zoho Adoption for Improved SEO & Content Creation Services Ultimovacs ASA: Invitation to third quarter 2021 results presentation
Oslo, 3 November 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune…
Immunicum Announces Nomination Committee for the 2022 Annual General Meeting
Press Release November 3, 2021 Immunicum Announces Nomination Committee for the 2022 Annual General Meeting…
Novo Nordisk’s net profit increased by 12% in the first nine months of 2021
Financial report for the period 1 January 2021 to 30 September 2021 3 November 2021 …
Sequana Medical Receives MDSAP Certification and Expands its Quality Management System Towards North America
GHENT, Belgium, Nov. 03, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the…
Valneva Announces Closing of Approximately $102.0 Million Global Offering
Saint-Herblain (France), November 3, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”),…
Burning Rock Schedules Third Quarter of 2021 Earnings Release on November 16, 2021
GUANGZHOU, China, Nov. 03, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange
CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…
Ocugen to Host Conference Call on Tuesday, November 9 at 8:30 a.m. ET to Discuss Third Quarter 2021 Financial Results and Provide Business Update
MALVERN, Pa., Nov. 02, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
New Clinical Data on GENFIT’s Investigational Compound Elafibranor to be Presented at AASLD The Liver Meeting®
Lille, France; Cambridge, MA; November 02, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
Tarsus to Participate in the Virtual Credit Suisse 30th Annual Healthcare Conference
IRVINE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
Oncternal Therapeutics Announces Formation of Cell Therapy Scientific Advisory Board
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Oyster Point Pharma to Present Data at the American Academy of Optometry Annual Meeting 2021
PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Timber Pharmaceuticals Announces Proposed Public Offering
Basking Ridge, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc….
Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Aquestive Therapeutics Reports Third Quarter 2021 Financial Results, Provides Business Update and Improves Full Year Guidance
Libervant™ (diazepam) Buccal Film continues to progress through the FDA review process in advance of…
Entrada Therapeutics Announces Closing of Initial Public Offering
BOSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company…
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. On-going Phase 2b clinical…
Opiant Announces Publication of Manuscript Treatment of Overdose in the Synthetic Opioid Era in Peer-Reviewed Journal Pharmacology & Therapeutics
SANTA MONICA, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT),…
Calithera Biosciences to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a…
Agile Therapeutics Reports Third Quarter 2021 Financial Results
Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla…